The estimated Net Worth of Clay Richards is at least $92 Mille dollars as of 19 April 2021. Clay Richards owns over 21,700 units of agilon health, inc stock worth over $91,986 and over the last 4 years Clay sold AGL stock worth over $0.
Sign up
Clay Richards AGL stock SEC Form 4 insiders trading
Clay has made over 1 trades of the agilon health, inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Clay bought 21,700 units of AGL stock worth $499,100 on 19 April 2021.
The largest trade Clay's ever made was buying 21,700 units of agilon health, inc stock on 19 April 2021 worth over $499,100. On average, Clay trades about 5,425 units every 0 days since 2021. As of 19 April 2021 Clay still owns at least 28,656 units of agilon health, inc stock.
You can see the complete history of Clay Richards stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Clay Richards's mailing address?
Clay's mailing address filed with the SEC is C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN, TX, 78723.
Insiders trading at agilon health, inc
Over the last 4 years, insiders at agilon health, inc have traded over $2,766,210,380 worth of agilon health, inc stock and bought 408,814 units worth $1,411,859 . The most active insiders traders include Investment Associates Ix, L..., Veeral Desai e Benjamin Shaker. On average, agilon health, inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,807,999. The most recent stock trade was executed by Benjamin Kornitzer on 14 March 2024, trading 5,434 units of AGL stock currently worth $17,443.
What does agilon health, inc's logo look like?
Complete history of Clay Richards stock trades at agilon health, inc
agilon health, inc executives and stock owners
agilon health, inc executives and other stock owners filed with the SEC include:
-
Steven Jackson Sell,
Pres, CEO & Director -
Dr. Benjamin Kornitzer M.D.,
Chief Medical & Quality Officer -
Mat Varghese,
Chief People Officer -
Ben Shaker,
Chief Markets Officer -
Claire Mulhearn,
Chief Communications & Public Affairs Officer -
Lisa Ali,
Chief Compliance Officer -
Lyn Amor Macaraeg,
VP of Legal Services -
Matthew Dale Gillmor CFA,
VP of Investor Relations -
Girish Venkatachaliah,
Chief Technology Officer -
Timothy S. Bensley,
Chief Financial Officer -
Silvana Battaglia,
Director -
Timothy Bensley,
Chief Financial Officer -
Joan Danieley,
Chief Administrative Officer -
Theodore Halkias,
Chief Business Officer -
Michelle A Gourdine,
Director -
Veeral Desai,
Chief Strategy & Dev. Officer -
Lisa Dombro,
Exper. & Innovation Officer -
Clay Richards,
Director -
Sharad Mansukani,
Director -
Benjamin Kornitzer,
Chief Med. & Quality Officer -
Benjamin Shaker,
Chief Markets Officer -
Ronald A Williams,
Director -
Glenn Sobotka,
Chief Accounting Officer -
Girish Venkatachaliah,
Chief Technology Officer -
John William Wulf,
Director -
Michael L Smith,
Director -
Karen Mc Loughlin,
Director -
Richard J Schnall,
Director -
Investment Associates Ix, L...,
-
Steven Sell,
CEO & President -
Jeffrey A. Schwaneke,
Chief Financial Officer -
Diana Mckenzie,
Director -
Priscilla Kasenchak,
Chief Accounting Officer -
Timothy Gertsch,
Chief Accounting Officer